Infectious Coryza in Poultry and Ducks: Etiology, Clinical Signs in Chickens, Differential Diagnosis from Avian Influenza, and Prevention Strategies

Abstract

Infectious coryza is an acute upper respiratory disease of gallinaceous birds caused by the bacterium Avibacterium paragallinarum. The disease is characterized by serous to mucopurulent nasal discharge, facial edema, conjunctivitis, and in severe cases, swelling of the infraorbital sinuses. While primarily a disease of chickens, infectious coryza has been documented in ducks, quail, and other avian species. This article provides a detailed review of the etiology, clinical presentation in chickens, differential diagnosis from highly pathogenic avian influenza (HPAI), and evidence based prevention strategies. The discussion emphasizes bacteriological and molecular diagnostic approaches, antimicrobial susceptibility patterns, and vaccination protocols. A differential diagnostic algorithm is presented to distinguish infectious coryza from avian influenza and other respiratory pathogens.

Etiology

Infectious coryza is caused by Avibacterium paragallinarum, a Gram negative, non motile, pleomorphic rod belonging to the family Pasteurellaceae. The bacterium is catalase negative, oxidase positive, and requires nicotinamide adenine dinucleotide (NAD, also known as V factor) for in vitro growth. This growth factor dependency is a key phenotypic feature used for laboratory identification.

Taxonomy and Serotyping

Avibacterium paragallinarum is classified into three serogroups (A, B, and C) based on hemagglutination inhibition assays. Serogroups A and C are further divided into multiple serovars. The Page scheme, which uses whole cell antigens, is the most widely accepted serotyping system. Serovar diversity has implications for vaccine efficacy, as cross protection between serovars is incomplete.

Pathogenesis

The bacterium colonizes the nasal mucosa and infraorbital sinuses. Adhesion to ciliated epithelial cells is mediated by fimbriae and other surface adhesins. Following colonization, A. paragallinarum induces a local inflammatory response characterized by infiltration of heterophils and macrophages. The release of bacterial toxins, including a cytotoxin and a hemagglutinin, contributes to epithelial damage and exudate formation. The incubation period ranges from 24 to 72 hours after natural exposure.

Infectious Coryza in Ducks

Although infectious coryza is primarily a disease of chickens, natural and experimental infections have been reported in ducks. The clinical presentation in ducks is generally milder than in chickens. Affected ducks may exhibit serous nasal discharge, mild conjunctivitis, and occasional sinus swelling. Respiratory distress is less common. The role of ducks as reservoirs or carriers of A. paragallinarum is not fully characterized, but epidemiological data suggest that waterfowl can harbor the bacterium without showing overt clinical signs. This has implications for multi species poultry operations where ducks and chickens are raised in proximity.

Clinical Signs in Chickens

The clinical presentation of infectious coryza in chickens is highly characteristic. The disease typically begins with serous nasal discharge that progresses to mucopurulent exudate. Facial edema, particularly around the infraorbital sinuses, is a hallmark sign. Conjunctivitis with frothy ocular discharge is common. In severe cases, the swelling can cause the eye to become completely swollen shut, a condition often described as "infectious coryza chicken eye swollen shut." This presentation is frequently mistaken for other respiratory infections.

Clinical Progression

The disease course can be divided into three phases:

1. Acute phase (days 1-3): Serous nasal discharge, sneezing, and mild conjunctivitis. Birds remain alert but may show reduced feed intake.

2. Exudative phase (days 4-7): Nasal discharge becomes mucopurulent and tenacious. Facial edema becomes pronounced. The infraorbital sinuses are visibly distended. Affected birds may shake their heads to dislodge exudate. Dyspnea may develop if the nasal passages become obstructed.

3. Chronic phase (days 8-14): Clinical signs gradually resolve in uncomplicated cases. However, secondary bacterial infections, particularly with Escherichia coli or Mycoplasma gallisepticum, can prolong the disease and increase mortality.

Morbidity and Mortality

Morbidity in susceptible flocks can reach 100%. Mortality is typically low (1-5%) in uncomplicated cases but can increase substantially when secondary pathogens are involved. Mortality rates of 20-30% have been reported in flocks co infected with E. coli or M. gallisepticum.

Differential Diagnosis from Avian Influenza

Differentiating infectious coryza from highly pathogenic avian influenza (HPAI) is a critical diagnostic challenge. Both diseases can present with facial edema, nasal discharge, and conjunctivitis. However, several clinical and pathological features aid in differentiation.

Clinical Differentiation

Pathological Differentiation

Gross lesions in infectious coryza are limited to the upper respiratory tract. The nasal passages and infraorbital sinuses contain copious mucopurulent exudate. In contrast, HPAI produces systemic lesions including hemorrhages on the serosal surfaces, pancreatic necrosis, and myocardial necrosis. Histologically, infectious coryza shows a suppurative rhinitis and sinusitis with heterophil infiltration. HPAI shows necrotizing inflammation in multiple organs with lymphocytic depletion.

Laboratory Confirmation

Definitive differentiation requires laboratory testing. For infectious coryza, isolation of A. paragallinarum on chocolate agar or NAD supplemented media is the gold standard. Molecular detection using PCR targeting the haemagglutinin gene or 16S rRNA is highly sensitive and specific. For avian influenza, virus isolation in embryonated chicken eggs or detection of influenza A matrix gene by real time RT PCR is required. Serological tests, such as the hemagglutination inhibition assay, can be used for retrospective diagnosis.

Diagnostic Algorithm

The following decision tree outlines the diagnostic approach for a flock presenting with acute respiratory signs.

graph TD
    A[Flock presents with respiratory signs], > B{Nasal discharge and facial edema?}
    B, >|Yes| C[Consider infectious coryza or avian influenza]
    B, >|No| D[Consider other respiratory pathogens]
    C, > E{Neurologic signs or high mortality?}
    E, >|Yes| F[Test for avian influenza]
    E, >|No| G[Test for infectious coryza]
    F, > H[Real time RT PCR for influenza A]
    G, > I[Bacterial culture on NAD supplemented media]
    I, > J{Isolation of A. paragallinarum?}
    J, >|Yes| K[Confirm infectious coryza]
    J, >|No| L[PCR for A. paragallinarum]
    L, > M{Positive?}
    M, >|Yes| K
    M, >|No| N[Consider other causes]
    D, > O[Test for Mycoplasma, E. coli, or viruses]

Prevention Strategies

Prevention of infectious coryza relies on biosecurity, vaccination, and antimicrobial stewardship.

Biosecurity

Infectious coryza is transmitted horizontally via direct contact, aerosolized droplets, and contaminated fomites. Strict biosecurity measures include:

• All in all out flock management.
• Disinfection of equipment and footwear between flocks.
• Quarantine of new birds for at least 14 days.
• Control of wild birds and rodents that may act as mechanical vectors.
• Separation of different age groups and species (e.g., ducks from chickens).

Vaccination

Vaccination is the most effective control measure in endemic areas. Both inactivated bacterins and live attenuated vaccines are available. Bacterins are typically administered via subcutaneous or intramuscular injection at 8-12 weeks of age, with a booster 4-6 weeks later. Autogenous vaccines, prepared from local serovars, are often used when commercial vaccines fail to provide adequate protection.

Vaccine efficacy is serovar specific. A vaccine containing serogroups A, B, and C is recommended for broad protection. In layers and breeders, vaccination is critical to prevent egg production losses.

Antimicrobial Therapy

Treatment of infectious coryza is primarily supportive, but antimicrobials can reduce the severity and duration of clinical signs. A. paragallinarum is susceptible to several antimicrobial classes, including:

• Tetracyclines (e.g., oxytetracycline, doxycycline)
• Macrolides (e.g., tylosin, tilmicosin)
• Sulfonamides (e.g., sulfadimethoxine)
• Fluoroquinolones (e.g., enrofloxacin)

Antimicrobial susceptibility testing is recommended due to the emergence of resistant strains. Treatment should be administered in the drinking water for 3-5 days. In severe cases, individual bird therapy with injectable oxytetracycline may be warranted.

Flock Management

Supportive care includes providing adequate ventilation, reducing stocking density, and ensuring access to clean water and feed. Affected birds should be isolated to reduce transmission. Culling of chronically affected birds may be necessary to eliminate carriers.

Conclusion

Infectious coryza remains a significant respiratory disease of poultry, with implications for both commercial and backyard flocks. The causative agent, Avibacterium paragallinarum, produces characteristic clinical signs that must be differentiated from avian influenza and other respiratory pathogens. Accurate diagnosis relies on bacterial culture and molecular methods. Prevention through biosecurity and vaccination is the cornerstone of control. Antimicrobial therapy should be guided by susceptibility testing to minimize the development of resistance. The recognition of infectious coryza in ducks underscores the need for vigilance in multi species poultry operations.

References

1. Blackall PJ, Christensen H, Beckenham T, et al. Reclassification of Pasteurella gallinarum, [Haemophilus] paragallinarum, and Pasteurella avium as Avibacterium gallinarum gen. nov., comb. nov., Avibacterium paragallinarum comb. nov., and Avibacterium avium comb. nov. International Journal of Systematic and Evolutionary Microbiology. 2005;55(1):353-362.

2. Yamamoto R. Infectious coryza. In: Saif YM, Barnes HJ, Glisson JR, et al., editors. Diseases of Poultry. 11th ed. Ames: Iowa State Press; 2003. p. 670-680.

3. Bragg RR. Virulence of South African isolates of Haemophilus paragallinarum. Part 1: NAD dependent field isolates. Onderstepoort Journal of Veterinary Research. 2002;69(2):131-139.

4. Soriano VE, Blackall PJ, Dabo SM, et al. Serotyping of Haemophilus paragallinarum isolates from Mexico by the Kume hemagglutinin scheme. Avian Diseases. 2001;45(3):680-683.

5. Sandoval VE, Terzolo HR, Blackall PJ. Complicated infectious coryza outbreaks in Argentina. Avian Diseases. 1994;38(3):672-678.

6. World Organisation for Animal Health (WOAH). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 3.3.2: Infectious coryza. Paris: WOAH; 2023.

7. Droual R, Bickford AA, Charlton BR, et al. Infectious coryza in meat chickens in the San Joaquin Valley of California. Avian Diseases. 1990;34(4):1009-1016.

8. Blackall PJ, Matsumoto M, Yamamoto R. Infectious coryza. In: Swayne DE, editor. Diseases of Poultry. 14th ed. Hoboken: Wiley-Blackwell; 2020. p. 789-804.